Sharp Lab
Phil's icon


printab
le PDF

CURRICULUM VITAE

Phillip A. Sharp, Ph.D.
Institute Professor


PROFESSIONAL ADDRESS

David H. Koch Institute for Integrative Cancer
Research at MIT, formerly the MIT
Center for Cancer Research

Room 76-461A
Massachusetts Institute of Technology
77 Massachusetts Avenue
(or 500 Main Street for express mail or courier service)
Cambridge, MA  02139-4307
Phone Number:  617-253-6421
Fax Number:  617-253-3867
E. mail:  sharppa@mit.edu


EDUCATION

1966:  B.A., Chemistry & Mathematics, Union College, Barbourville, KY
1969:  Ph.D., Chemistry, University of Illinois, Urbana



POSITIONS

1999-date:   Institute Professor, MIT
2000-2004:  Director, The McGovern Institute, MIT
1991-1999:  Salvador E. Luria Professor of Biology, MIT
1991-1999:  Head, Department of Biology, MIT
1987-1992:  John D. MacArthur Professor of Biology, MIT
1985-1991:  Director, Center for Cancer Research, MIT
1982-1985:  Associate Director, Center for Cancer Research, MIT
1979-1999:  Professor, Center for Cancer Research and Department of Biology, MIT
1974-1979:  Associate Professor, Center for Cancer Research and Department of Biology, MIT
1972-1974:  Senior Research Investigator, Cold Spring Harbor Laboratory, CSH, New York
1971-1972:  Postdoctoral Fellow, Cold Spring Harbor Laboratory
1969-1971:  Postdoctoral Fellow, California Institute of Technology
1966-1669:  Research Assistant/Graduate Student, Department of Chemistry, University of Illinois



HONORS AND AWARDS

2014: The SU2C Phillip A. Sharp Innovation in Collaboration Awards to foster collaboration among members of the SU2C scientific community that would enhance the SU2C mission to accelerate the development of new cancer treatments.
2013: Elected Fellow of the AACR Academy
2013: The Lifetime Achievement in Science Award from the RNA Society
2013: Selected a Vallee Visiting Professor
2013: President, American Association for the Advancement of Sciences (AAAS)
2013: Award of Excellence from the Hope Funds for Cancer Research 2012: Honorary Degree of Doctor of Science, McGill University, Montreal, QC, Canada
2012: The Christian A. Herter Lecture, New York University School of Medicine
2012: Han-Mo Koo Memorial Lecture, Van Andel Research Institute, Grand Rapids, MI
2012: President-Elect, American Association for the Advancement of Science (AAAS)
2011: Elected Foreign Fellow of the Royal Society, UK
2011: Honorary Degree, Doctor of Science, University of Minnesota
2010: AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
2010: American Society for Biochemistry and Molecular Biology Herbert Tabor/Journal of Biological Chemistry Lectureship
2009: Honorary Academician of the Academia Sinica of Taiwan
2008: Honorary Academician of Academia Sinica, Republic of China
2008: Honorary Doctorate, Eberly College of Science (Penn State), State College, Pennsylvania
2008: Honorary Doctorate, Bates College, Maine
2007: The Karl Friedrich Bonhoeffer Lecture, Max Planck Institute, Göttigen, Germany
2007: The Winthrop-Sears Award from the Chemists’ Club of New York
2006: The Inaugural Double Helix Medal for Scientific Research from Cold Spring Harbor Laboratory
2006: Honorary Doctorate, Rippon College, Ripon, Wisconsin
2006: The AACR Irving Weinstein Distinguished Lectureship Award
2005: The 2004 National Medal of Science
2005: Third Princess Chulabhorn Distinguished Lecturer, Chulabhorn Resesarch Institute, Bangkok, Thailand
2005: KT Wang Foundation Bioorganic Chemistry Lecturer, The National Taiwan University and Academia Cinica, Taiwan
2005: The University College Dublin Ulysses Inaugural Lecturer, Dublin, Ireland
2004: Honorary Member, The National Academy of Sciences-Republic of Korea
2003: Novartis Drew Award in Biomedical Research
2003: Received the University of Illinois Alumni Achievement Award
2002: The Fourth Annual Biotechnology Heritage Award from the Biotechnology Industry Organization (BIO) and the Chemical Heritage Foundation (CHF)
2002: The Storer Life Sciences Lectures, University of California, Davis
2002: Elected Honorary Fellow of the Royal Society of Edinburgh, Scotland
2002: Lifetime Honorary Member of the Kentucky Academy of Sciences
2001: Honorary Doctorate, Northern Kentucky University
2001: The Norman Davidson Lecture, California Institute of Technology
2001: The Walker Prize from the Museum of Science, Boston, MA
1999: Doctor Honoris Causa, University of Buenos Aires, Argentina
1999: Honorary Doctor of Medicine, Uppsala University, Sweden
1999: Institute Professor, MIT
1999: The Benjamin Franklin Medal of the American Philosophical Society
1999: Honorary Doctor of Science, Thomas More College, KY
1998: Honorary Doctor of Science, University of Glasgow, Scotland
1996: Honorary Doctor of Science, Albright College, Reading, PA
1996: Honorary Doctor of Science, University of Tel Aviv
1995: Honorary Doctor of Science Degree, Bowdoin College, Brunswick, ME
1994: Honorary Doctor of Science Degree, University of Kentucky
1993: The Nobel Prize in Physiology or Medicine
1993: Elected Fellow of the American Academy of Microbiology
1993: The James R. Killian, Jr., Faculty Achievement Award, MIT
1993: The Mendel Medal Award from Villanova University, Villanova, PA
1992-1999: The Inaugural Salvador E. Luria Professorship (Chair), MIT
1991: Honorary Degree of Doctor of Humane Letters from Union College, Barbourville, KY
1991: Elected Member of the American Philosophical Society
1991: Elected Member of the Institute of Medicine of the National Academy of Sciences
1990: The Dickson Prize, University of Pittsburgh
1988: The Albert Lasker Basic Medical Research Award
1988: Louisa Gross Horwitz Prize, Columbia University
1987-1992: The John D. MacArthur Professorship (Chair), MIT
1987: Elected Fellow of the American Association for the Advancement of Science
1987-1990: Elected Councilor of the National Academy of Sciences
1986: The New York Academy of Sciences Award in Biological and Medical Sciences
1986: The Gairdner Foundation International Award, Canada
1986: The General Motors Research Foundation Alfred P. Sloan, Jr. Prize for Cancer Research
1986-1987: Class of ‘41 Professorship (Chair), MIT
1985: The Howard Ricketts Award, The University of Chicago
1985: The Harvey Society Lecture
1983: Elected to the National Academy of Sciences
1983: Elected to the American Academy of Arts and Sciences
1980: The Eli Lilly Award in Biological Chemistry
1980: The National Academy of Sciences’ U.S. Steel Foundation Award in Molecular Biology
1974-1979: Recipient of an American Cancer Society Career Development Award  



SERVICE

Member of the advisory committee, MIT’s new Institute for Medical Engineering and Science (IMES), 2012
Member of the HHMI Review Committee, 2011
Member of the World Economic Forum (WEF) Technology Pioneers Program 2010 Selection Committee in the Area of Biotechnology/Health, 2010
Co-Chair of MIT’s Production in an Innovation Economy (PIE) Commission, 2010
Ad Hoc Member of the Committee to Consider the Future of HST at MIT, 2010
Ad hoc member of the NIH/MIT Convergence White Paper on "The Third Revolution: Convergence of the Life Sciences, Physical Sciences and Engineering, 2010
Co-Chair of the National Cancer Advisory Board (NCAB) Working Group of the National Cancer Institute (NCI), NIH, 2010
Chair of the Scientific Review Council of the Cancer Prevention and Research Institute of Texas (CPRIT)– 2009-2012
Co-chair, NRC Committee on A New Biology for the 21st Century: Ensuring the United States Leads the Coming Biology Revolution, National Academy of Sciences, 2008-2010
Chair of the Scientific Advisory Committee, SU2C Project, AACR, 2008-
Member of the Board of FDA’s Reagan-Udall Foundation, 2008-
Member of the Alfred P. Sloan Management Society of the MIT Sloan School of Management, 2007-
Elected member of the MIT Museum Advisory Board, 2005-
Member of the National Academies Committee on Scientific Communication and National Security (CSCANS), 2005-2009
Member, Lasker Jury of the Lasker Foundation, 2007-
Member of the Scientific Advisory Board of the Ontario Institute for Cancer Research (OICR), 2006-
Elected Member of the Board of Directors of the Whitehead Institute, 2005-
Member of the Gairdner Foundation Awards Committee, 2004-
Elected Member of the Corporation of Partners HealthCare Systems, Inc., 2003-
Member of the Board of Trustees of the Massachusetts General Hospital, 2002-
Member and Chair, Committee on Research and Education, Partners HealthCare Systems Inc., 2003-
Member of the Nominating Committee, Partners HealthCare Systems Inc., 2005-
Member of the Board of Scientific Governors of the Scripps Research Institute, 1999-
Member of the Science Advisory Committee for the Sandler Basic Science Program, UCSF, 1999-2007
Member of the Scientific Committee of the Ludwig Institute for Cancer Research, 1998-2008
Member of the Scientific Board of Advisors, The Van Andel Institute, 1996-
Chairman of the Scientific and Medical Advisory Board of the Huntsman Cancer Foundation, 1995-2001
Trustee and Member of the Alfred P. Sloan Foundation, 1995-2004
Chairman of the General Motors Cancer Research Foundation Awards Assembly, 1994-2006
Member of the Faculty of the Harvard-MIT Division of Health Sciences and Technology
Member of the Review Committee, The Medical Foundation (Health Resources in Action), 1982-2005, and its Chairman, 1988-2005
Member of the Advisory Council of the Molecular Biology Department, Princeton University, 1987- 2003


GOVERNMENT SERVICE

Member of the NCI Translational Science Program, 2010
Committee on Science Engineering and Public Policy (COSEPUP), Assuring the Integrity of Research Data in an Era of E-Science, National Academy of Sciences, 2007-
NHGRI Large-Scale Sequencing Program, committee member - current
NSAB committee member - current
MGC ESC committee member - current
Member of the National Cancer Advisory Board (NCAB), NCI , 1996-2000
Chairman of the National Cancer Advisory Board (NCAB), NCI, 2000-2002
Member of the NCI Advisory Committee to the Director, 2000-2001
Member of the President’s Committee of Advisors on Science and Technology (PCAST), 1994-97
Member, Committee on Science, Engineering, and Public Policy (COSEPUP), 7/1/92-6/30/95


INDUSTRY

Member of the Scientific Advisory Board of Sirtris Pharmaceuticals, 2003-2010
Member of the Scientific Advisory Board of Fidelity Biosciences Group, 2004-
Member of the Board of Advisors, Polaris Venture Partners, 2002-
Member of the Advisory Board of Verastem, 2010-
Advisor and Investor in the Longwood Fund, 2010-
Member of the Board of Directors of Syros Pharmaceuticals, 2012-
Co-founder of Biogen, Inc., 1978 (now Biogen Idec), Chairman of the Scientific Board (to 2002) and member of the Board of Directors (to 2009)
Co-founder of Alnylam Pharmaceuticals (2002), Chairman of the Scientific Board and member of the Board of Directors


PROFESSIONAL SOCIETIES

The National Academy of Sciences
The Institute of Medicine
The American Association for the Advancement of Science
The American Society of Biological Chemists
The American Association for Cancer Research
The American Chemical Society
The American Society for Microbiology
The American Academy of Arts and Sciences
The American Society for Biochemistry and Molecular Biology
The American Philosophical Society



EDITORIAL BOARDS

J. Virol. (to 1985); Mol. Cell. Biol. (to 1985); Virology (to 1986); Cell (to 1995); RNA (1995-)



PUBLICATIONS

1.      Bloomfield, V. A. and Sharp, P. A.  Variation in intrinsic viscocity f parameter with chain topology, hydrodynamic interaction and excluded volume.  Macromol. 1, 380 (1968).

2.      Sharp, P. A. and Bloomfield, V. A.  Light scattering from wormlike chains with excluded volume effects.  Biopolymers  6, 1201-1211 (1968).

3.      Sharp, P. A. and Bloomfield, V. A.  Light scattering and hydrodynamic properties of polymer chains with excluded volume effects.  J. Chem. Phys. 49, 4564-4566 (1968).

4.      Sharp, P. A. and Bloomfield, V. A.  Intrinsic viscosity of wormlike chains with excluded-volume effects.  J. Chem. Phys. 48, 2149-2155 (1968).

5.      Sharp, P. A., and Bloomfield, V. A.  Binding of proflavine and ethidium bromide to two forms of T2 bacteriophage with different sedimentation coefficients.  Biochem. Biophys. Res. Commun. 39, 407-413 (1970). 

5a.      Cohen, S. N., Silver, R. P., Sharp, P. A., and McCoubrey, A. E.  The problems of drug-resistant pathogenic bacteria.  Studies on the molecular nature of R factors.  Ann. NY Acad. Sci. 182, 172-187 (1971). 

6.      Cohen, S. N., Silver, R. P., McCoubrey, A. E., and Sharp, P. A.  Isolation of cotenated forms of R factor DNA from inicells.  Nature New Biol. 231, 249-251 (1971).

7.      Kim, J., Sharp, P. A., and Davidson, N.  Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174.  Proc. Natl. Acad. Sci. USA 69, 1948-1952 (1972).

8.      Tai, H. T., Smith, C. A., Sharp, P. A., and Vinograd, J.  Sequence heterogeneity in closed simian virus 40 deoxyribonucleic acid.  J. Virol. 9, 317-325 (1972).

9.      Sharp, P. A., Hsu, M., and Davidson, N.  Note on the structure of prophage l.   J. Mol. Biol. 71, 499-501 (1972).

10.     Sharp, P. A., Hsu, M. T., Otsubo, E., and Davidson, N.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli.  I. Structure of F-prime factors.  J. Mol. Biol. 71, 471-497 (1972).

11.     Sambrook, J., Sharp, P. A., and Keller, W.  Transcription of Simian virus 40.  I.  Separation of the strands of SV40 DNA and hybridization of the separated strands to RNA extracted from lytically infected and transformed cells.  J. Mol. Biol. 70, 57-71 (1972).

12.     Ozanne, B., Sharp, P. A., and Sambrook, J.  Transcription of simian virus 40.  II.  Hybridization of RNA extracted from different lines of transformed cells to the separated strands of simian virus 40 DNA.  J. Virol. 12, 90-98 (1973).

13.     Sambrook, J., Sugden, B., Keller, W., and Sharp, P. A.  Transcription of simian virus 40.  III.  Mapping of “early” and “late” species of RNA.  Proc. Natl. Acad. Sci. USA 70, 3711-3715 (1973).

14.     Botchan, M., McKenna, G., and Sharp, P. A.  Cleavage of mouse DNA by a restriction enzyme as a clue to   the arrangement of genes.  Cold Spring Harbor Symp. Quant. Biol. 38, 383-395 (1974).  

14a.   Botchan, M., Ozanne, B., Sugden, B., Sharp, P. A., and Sambrook, J.  Viral DNA in transformed cells.  III.  The amounts of different regions of the SV40 genome present in a line of transformed mouse cells.  Proc. Natl. Acad. Sci. USA 71, 4183-4187 (1974).

15.     Sharp, P. A., Sugden, B., and Sambrook, J.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose-ethidium bromide electrophoresis.  Biochemistry 12, 3055-3063 (1973).

16.     Sharp, P. A., Cohen, S. N., and Davidson, N.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli.  II.  Structure of drug resistance ® factors and F factors.  J. Mol. Biol. 75, 235-255 (1973).

17.     Pettersson, U., Mulder, C., Delius, H., and Sharp, P. A.  Cleavage of adenovirus type 2 DNA into six unique fragments by endonuclease R-RI.  Proc. Natl. Acad. Sci. USA 70, 200-204 (1973).

18.     Sharp, P. A., Pettersson, U., and Sambrook, J.  Viral DNA in transformed cells.  I.  A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.  J. Mol. Biol. 86, 709-726 (1974).

19.     Mulder, C., Sharp, P. A., Delius, H., and Pettersson, U.   Specific fragmentation of DNA of adenovirus serotypes 3, 5, 7, and 12, and adeno-simian virus 40 hybrid virus Ad2+ND1 by restriction endonuclease R.EcoRI.   J. Virol. 14, 68-77 (1974).   

19a.    Sambrook, J., Sharp, P. A., Ozanne, B., and Pettersson, U.   Studies on the transcription of simian virus 40 and adenovirus type 2.  Basic Life Sci. 3, 167-179 (1974).

20.     Sharp, P. A., Gallimore, P. H., and Flint, S. J.  Mapping of adenovirus 2 RNA sequences in lytically infected cells and transformed cell lines.  Cold Spring Harbor Symp. Quant. Biol. 39, 457-474 (1975).

21.     Flint, S. J. and Sharp, P. A.  Mapping of viral-specific RNA in the cytoplasm and nucleus of adenovirus 2-infected human cells.  Brookhaven Symp. Biol. 26, 333-358 (1975).

22.     Mulder, C., Arrand, J. R., Delius, H., Keller, W., Pettersson, U., Roberts, R. J., and Sharp, P. A.  Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaI.  Cold Spring Harbor Symp. Quant. Biol. 39, 397-400 (1975).

23.     Grodzicker, T., Anderson, C., Sharp, P. A., and Sambrook, J.  Conditional lethal mutants of adenovirus 2-simian virus 40 hybrids. I.  Host range mutants of Ad2+ND1.  J. Virol. 13, 1237-1244 (1974).

24.     Gallimore, P. H., Sharp, P. A., and Sambrook, J.  Viral DNA in transformed cells.  II.  A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cell using specific fragments of the viral genome.  J. Mol. Biol. 89, 49-72 (1974).

25.     Sambrook, J., Botchan, M., Gallimore, P., Ozanne, B., Pettersson, U., Williams, J., and Sharp, P. A.  Viral DNA sequences in cells transformed by simian virus 40, adenovirus type 2 and adenovirus type 5.  Cold Spring Harbor Symp. Quant. Biol. 39, 615-632 (1975).   

 25a.   Grodzicker, T., Williams, J., Sharp, P., and Sambrook, J.  Physical mapping of temperature-sensitive mutations of adenoviruses.  Cold Spring Harbor Symp. Quant. Biol. 39, 439-446 (1975).

26.     Sambrook, J., Williams, J., Sharp, P. A., and Grodzicker, T.  Physical mapping of temperature-sensitive mutations of adenoviruses.  J. Mol. Biol. 97, 369-390 (1975).

27.     Williams, J., Grodzicker, T., Sharp, P. A., and Sambrook, J.  Adenovirus recombination:  physical mapping of crossover events.  Cell 4, 113-119 (1975).   

27a.   Sambrook, J., Jackson, A., Keller, W., Ozanne, B., Sharp, P. A., and Sugden, B.  “Transcription of SV40 in lytically infected and transformed cells.”  In Tumor virus-host cell interaction.  Kolber, A.R. (editor), New York:  Plenum Press, 91-116 (1975).

28.     Mautner, V., Williams, J., Sambrook, J., Sharp, P. A., and Grodzicker, T.  The location of the genes coding for hexon and fiber proteins in adenovirus DNA.  Cell 5, 93-99 (1975).

29.     Flint, S. J., Wewerka-Lutz, Y., Levine, A. S., Sambrook, J., and Sharp, P. A.  Adenovirus transcription.  II.  RNA sequences complementary to simian virus 40 and adenovirus 2 DNA in AD2+ND1- and AD2+ND3-infected cells.  J. Virol. 16, 662-673 (1975). 

30.     Flint, S. J., Gallimore, P. H., and Sharp, P. A.  Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells.  J. Mol. Biol. 96, 47-68 (1975).

31.     Sharp, P. A. and Flint, S. J.  Adenovirus transcription.  Current Topics Microbiol. Immunol. 74, 137-166 (1976).

32.     Flint, S. J., Berget, S. M., and Sharp, P. A.  Adenovirus transcription.  III.  Mapping of viral RNA sequences in cells productively infected by adenovirus type 5. Virology 72, 443-455 (1976).

33.     Flint, S. J., Sambrook, J., Williams, J. F., and Sharp, P. A.  Viral nucleic acid sequences in transformed cells.  IV.  A study of the sequences of adenovirus 5 DNA and RNA in four lines of adenovirus 5-transformed rodent cells using specific fragments of the viral genome. Virology 72, 456-470 (1976).

34.     Berget, S. M., Flint, S. J., and Sharp, P. A.  “Characterization of viral, single-stranded DNA sequences in adenovirus infected cells.”  In Animal virology.  (Baltimore, D., Huang, A. S., and Fox, C. F., eds.), New York:  Academic Press, 81-96 (1976).

35.     Berget, S. M., Flint, S. J., Williams, J. F., and Sharp, P. A.  Adenovirus transcription.  IV.  Synthesis of viral-specific RNA in human cells infected with temperature-sensitive mutants of adenovirus 5.  J. Virol. 19, 879-889 (1976).

36.     Flint, S. J. and Sharp, P. A.  Adenovirus transcription.  V.  Quantitation of viral RNA sequences in adenovirus 2-infected and transformed cells.  J. Mol. Biol. 106, 749-774 (1976).

37.     Sharp, P. A., Moore, C., and Haverty, J. L.  The infectivity of adenovirus 5 DNA-protein complex.  Virology 75, 442-456 (1976).

38.     Flint, S. J., Berget, S. M., and Sharp, P. A.  Characterization of single-stranded viral DNA sequences present during replication of adenovirus types 2 and 5.  Cell 9, 559-571 (1976).

39.     Berk, A. J. and Sharp, P. A.  Ultraviolet mapping of the adenovirus 2 early promoters.  Cell 12, 45-55 (1977).

40.     Donoghue, D. J. and Sharp, P. A.  An improved bacteriophage l vector:  construction of model recombinants coding for kanamycin resistance.  Gene 1, 209-227 (1977).

41.     Donoghue, D. J. and Sharp, P. A.  “Model recombinants for the development and manipulation of EK2 phage vector systems.”  In Molecular Approaches to Eucaryotic Genetic Systems: ICN-UCLA Symposia on Molecular and Cellular Biology (G. Wilcox et al., ed.), Vol. VIII, pp. 41-53, New York:  Academic Press (1977).

42.     Berget, S. M., Moore, C., and Sharp, P. A.  Spliced segments at the 5’ terminus of adenovirus 2 late mRNA.  Proc. Natl. Acad. Sci. USA 74, 3171-3175 (1977).

43.     Berk, A. J. and Sharp, P. A.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.  Cell 12, 721-732 (1977).

44.     Berget, S. M. and Sharp, P. A.  A spliced sequence at the 5’-terminus of adenovirus late mRNA.  In Gene Interaction and Transfer:  Brookhaven Symp. Biol. 29, 332-344 (1977).

45.     Berget, S. M., Berk, A. J., Harrison, T., and Sharp, P. A.  Spliced segments at the 5’ termini of adenovirus-2 late mRNA: a role for heterogeneous nuclear RNA in mammalian cells.  Cold Spring Harbor Symp. Quant. Biol. 42, 523-529 (1978).

46.     Donoghue, D. J. and Sharp, P. A.  Replication of colicin E1 plasmid DNA in vivo requires no plasmid-encoded proteins.  J. Bacteriol. 133, 1287-1294 (1978).

47.     Berk, A. J. and Sharp, P. A.  Spliced early mRNAs of simian virus 40.  Proc. Natl. Acad. Sci. USA 75, 1274-1278 (1978).

48.     Berk, A. J. and Sharp, P. A.  Structure of the adenovirus 2 early mRNAs.  Cell 14, 695-711 (1978).

49.     Donoghue, D. J., Rothenberg, E., Hopkins, N., Baltimore, D., and Sharp, P. A.  Heteroduplex analysis of the nonhomology region between Moloney MuLV and the dual host range derivative HIX virus.  Cell 14, 959-970 (1978).

50.     Berk, A. J. and Sharp, P. A.  “RNA splicing in the early mRNAs of simian virus 40 and adenovirus 2.”  In Persistent viruses: ICN-UCLA Symposia on Molecular and Cellular Biology  (J. G. Stevens et al., eds), New York: Academic Press, pp. 431-444 (1978).

51.     Donoghue, D. J. and Sharp, P. A.  Construction of a hybrid bacteriophage-plasmid recombinant DNA vector.  J. Bacteriol. 136, 1192-1196 (1978).

52.     Lockard, R. E., Berget, S. M., RajBhandary, U. L., and Sharp, P. A.  Nucleotide sequence at the 5’ terminus of adenovirus 2 late messenger RNA.  J. Biol. Chem. 254, 587-590 (1979).

53.     Berget, S. M. and Sharp, P. A.  Structure of late adenovirus 2 heterogeneous nuclear RNA.  J. Mol. Biol. 129, 547-565 (1979).

54.     Sharp, P. A., Berk, A. J., and Berget, S. M.  Transcription maps of adenovirus.  In  Methods in Enzymology 65, 750-768 (1979).

55.     Donoghue, D. J., Sharp, P. A., and Weinberg, R. A.  An MSV-specific subgenomic mRNA in MSV-transformed G8-124 cells.  Cell 17, 53-63 (1979).

56.     Manley, J. L., Sharp, P. A., and Gefter, M. L.  RNA synthesis in isolated nuclei: identification and comparison of adenovirus 2 encoded transcripts synthesized in vitro and in vivo.  J. Mol. Biol. 135, 171-197 (1979).

57.     Kronenberg, H. M., McDevitt, B. E., Majzoub, J. A., Nathans, J., Sharp, P. A., Potts, J. T., and Rich, A.  Cloning and nucleotide sequence of DNA coding for bovine preproparathyroid hormone.  Proc. Natl. Acad. Sci. USA 76, 4981-4985 (1979).

58.     Manley, J. L., Sharp, P. A., and Gefter, M. L.  RNA synthesis in isolated nuclei: in vitro initiation of adenovirus 2 major late mRNA precursor.  Proc. Natl. Acad. Sci. USA 76, 160-164 (1979).

59.     Berk, A. J., Lee, F., Harrison, T., Williams, J., and Sharp, P. A.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.  Cell 17, 935-944 (1979).

60.     Lee, F., Berk, A. J., Harrison, T., Williams, J., and Sharp, P. A.  Regulation of early adenovirus mRNA synthesis.  ICN-UCLA Symposia 48, 581-594 (1979).

61.     Donoghue, D. J., Sharp, P. A., and Weinberg, R. A.  Comparative study of different isolates of murine sarcoma virus.  J. Virol. 32, 1015-1027 (1979).

62.     Manley, J. L., Sharp, P. A., and Gefter, M. L.  Synthesis and processing of adenovirus 2 RNA in vitro.  ICN-UCLA Symposia 49, 595-610 (1979).

63.     Berk, A. J., Lee, F., Harrison, T., Williams, J., and Sharp, P. A.  Phenotypes of adenovirus-5 host-range mutants for early-mRNA synthesis.  Cold Spring Harbor Symp. Quant. Biol. 44, 429-436 (1980).

63a.   Donoghue, D. J., Goldfarb, M. P., Sharp, P. A., and Weinberg, R. A.  Organization of murine sarcoma virus genomes.  Cold Spring Harbor Symp. Quant. Biol. 44, 721-726 (1980).

64.     Sharp, P. A.  Summary: molecular biology of viral oncogenes. Cold Spring Harbor Symp. Quant. Biol. 44, 1305-1322 (1980).   

64a.    Sharp, P. A., Berk, A. J., and Berget, S. M.  Transcription maps of adenovirus.  Methods Enzymol. 65, 750-768 (1980).

           Sharp, P. A., Manley, J., Fire, A., and Gefter, M.  Regulation of adenovirus mRNA synthesis.  Annals NY Acad. Sci. 354, 1-15 (1980).

65.     Manley, J. L., Handa, H., Huang, S-Y., Gefter, M., and Sharp, P. A.  Transcription of animal genes in vitro.  Miami Symp., pp. 361-378 (1980).

66.     Handa, H. and Sharp, P. A.  Expression of early and late simian virus 40 transcripts in the absence of protein synthesis.  J. Virol.  34, 592-597 (1980).

67.     Sharp, P. A., Manley, J. L., Fire, A., and Gefter, M.  Regulation of adenovirus mRNA synthesis.  New York Academy of Sci. 354, 1-15 (1980).

68.     Manley, J. L., Fire, A., Cano, A., Sharp, P. A., and Gefter, M. L.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.  Proc. Natl. Acad. Sci. USA 77, 3855-3859 (1980).

69.     Sharp, P. A.  Workshop #3 Summary:  Adenoviruses/SV40/Polyoma II.  ICN-UCLA Symp. Proc., pp. 799-807 (1980).

70.     Cepko, C. L., Changelian, P. S., and Sharp, P. A.  Immunoprecipitation with two-dimensional pools as a hybridoma screening technique: production and characterization of monoclonal antibodies against adenovirus 2 proteins.  Virology 110, 385-401 (1981).

71.     Handa, H., Kaufman, R. J., Manley, J., Gefter, M., and Sharp, P. A.  Transcription of Simian virus 40 DNA in a HeLa whole cell extract.  J. Biol. Chem. 256, 478-482 (1981).

72.     Sharp, P. A.  Adenovirus late transcription unit.  In Perspectives in Virol., Vol. II, pp. 9-30 (M. Pollard, ed.), New York: Alan R. Liss, Inc. (1981).

73.     Chu, G., and Sharp, P. A.  A gene chimaera of SV40 and mouse beta-globin is transcribed and properly spliced.  Nature 289, 378-382 (1981).

74.     Chu, G., and Sharp, P. A.  SV40 DNA transfection of cells in suspension: analysis of efficiency of transcription and translation of T-antigen.  Gene 13, 197-202 (1981).

75.     Sharp, P. A.  Speculations on RNA splicing.  Cell 23, 643-646 (1981).

76.     Cepko, C. L., Hansen, U., Handa, H., and Sharp, P. A.  Sequential transcription-translation of simian virus   40 by using mammalian cell extracts.  Mol. Cell. Biol. 1, 919-931 (1981).

77.     Lemischka, I. R., Farmer, S., Racaniello, V. R., and Sharp, P. A.  Nucleotide sequence and evolution of a mammalian a-tubulin messenger RNA.  J. Mol. Biol. 151, 101-120 (1981).

78.     Fire, A., Baker, C. C., Manley, J. L., Ziff, E. B., and Sharp, P. A.  In vitro transcription of adenovirus.  J. Virol. 40,  703-719 (1981).

79.     Ricciardi, R. P., Jones, R. L., Cepko, C. L., Sharp, P. A., and Roberts, B. E.  Expression of early adenovirus genes requires a viral encoded acidic polypeptide.  Proc. Natl. Acad. Sci. USA 78, 6121-6125 (1981).

80.     Fire, A., Baker, C. C., Ziff, E. B., and Sharp, P. A.  Transcription of adenovirus DNA in infected cell extracts.  ICN-UCLA Symposia on Molecular and Cellular Biology XXIII (D. D. Brown and C. F. Fox, eds.), pp. 387-399, New York:  Academic Press (1981).

81.     Crawford, N., Fire, A., Samuels, M., Sharp, P. A., and Baltimore, D.  Inhibition of transcription factor activity by poliovirus.  Cell 27, 555-561 (1981).

82.     Hansen, U., Tenen, D. G., Livingston, D. M., and Sharp, P. A.  T-antigen repression of SV40 early transcription from overlapping promoters.  Cell 27, 603-612 (1981).

83.     Sharp, P. A. and Wilson, M. C.  Regulation of gene expression.  In Molecular Genetic Neuroscience, Chapter 5 (F. O. Schmitt, S. J. Bird, and F. E. Bloom, eds.), pp. 47-59, New York: Raven Press (1982).

84.     Manley, J. L., Sharp, P. A., and Gefter, M. L.  RNA synthesis in isolated nuclei:  Processing of adenovirus serotype 2 late messenger RNA precursors.  J. Mol. Biol. 159, 581-599 (1982).

85.     Laski, F. A., Alzner-DeWeerd, B., RajBhandary, U. L., and Sharp, P. A.  Expression of a X. laevis tRNATyr gene in mammalian cells.  Nucleic Acids Res. 10, 4609-4626 (1982).

86.     Horowitz, M., Cepko, C. L., and Sharp, P. A.  SV40 as a vector for cloning eukaryotic sequences that affect post-transcriptional processing.  In Eukaryotic Viral Vectors (Y. Gluzman, ed.), Cold Spring Harbor Laboratory, pp. 47-53 (1982).

87.     Berkner, K. L. and Sharp, P. A.  Preparation of adenovirus recombinants using plasmids of viral DNA.  In Eukaryotic Viral Vectors (Y. Gluzman, ed.), Cold Spring Harbor Laboratory, pp. 193-198 (1982).

88.     Kaufman, R. J., Sharp, P. A., and Latt, S. A.  Expression and amplification of DNA introduced into mammalian cells.  In Gene Amplification (S. Schimke, ed.), Cold Spring Harbor Press, pp. 245-250 (1982).

89.     Kaufman, R. J. and Sharp, P. A.  Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene.  J. Mol. Biol. 159, 601-621 (1982).

90.     Laski, F. A., Belagaje, R., RajBhandary, U. L., and Sharp, P. A.  An amber suppressor tRNA gene derived by site-specific mutagenesis: cloning and function in mammalian cells.  Proc. Natl. Acad. Sci. USA  79, 5813-5817 (1982).

91.     Hudziak, R. M., Laski, F. A., RajBhandary, U. L., Sharp, P. A., and Capecchi, M.  Establishment of mammalian cell lines containing multiple nonsense mutations and functional suppressor tRNA genes.  Cell 31, 137-146 (1982).

92.     Cepko, C. L. and Sharp, P. A.  Assembly of adenovirus major capsid protein is mediated by a nonvirion protein.  Cell 31, 407-415 (1982).

93.     Lemischka, I. and Sharp, P. A.  The sequences of an expressed rat a-tubulin gene and a pseudogene with an inserted repetitive element.  Nature 300, 330-335 (1982).

94.     Kaufman, R. J. and Sharp, P. A.  Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression.  Mol. Cell. Biol. 2, 1304-1319 (1982).

95.     Samuels, M., Fire, A., and Sharp, P. A.  Separation and characterization of factors mediating accurate transcription by RNA polymerase II.  J. Biol. Chem. 257, 14419-14427 (1982).

96.     Kaufman, R. J., and Sharp, P. A.  Growth-dependent expression of dihydrofolate reductase mRNA from modular cDNA genes.  Mol. Cell. Biol. 3, 1598-1608 (1983).

97.     Sharp, P. A., Fire, A., Samuels, M., and Crawford, N.  In vitro transcription of adenovirus DNA.  Proceedings of the 35th Annual Symp. Fundamental Cancer Research:  Perspectives on Genes and the Molecular Biology of Cancer (D. L. Robberson and G. F. Saunders, eds.), New York: Raven Press, pp. 255-263 (1983).

98.     Cepko, C. L., Whetstone, C. A., and Sharp, P. A.  Adenovirus hexon monoclonal antibody that is group specific and potentially useful as a diagnostic reagent.  J. Clin. Microbiol. 17, 360-364 (1983).

99.     Sharp, P. A.  Conversion of RNA to DNA in mammals: Alu-like elements and pseudogenes.  Nature 301, 471-472 (1983).

100.   Cepko, C. L., and Sharp, P. A.  Aberrant distribution of human adenovirus type 2 late proteins in monkey kidney cells.  J. Virol.  46, 302-306 (1983).

101.   Handa, H., Kingston, R. E., and Sharp, P. A.  Inhibition of adenovirus early region IV transcription in vitro by a purified viral DNA binding protein.  Nature 302, 545-547 (1983).

102.   Horowitz, M., Cepko, C. L., and Sharp, P. A.  Expression of chimeric genes in the early region of SV40.  J. Mol. Appl. Genet. 2, 147-159 (1983).

103.   Padgett, R. A., Hardy, S. F., and Sharp, P. A.  Splicing of adenovirus RNA in a cell-free transcription system.  Proc. Natl. Acad. Sci. USA 80, 5230-5234 (1983).

104.   Cepko, C. L. and Sharp, P. A.  Analysis of Ad5 hexon and 100K ts mutants using conformation-specific monoclonal antibodies.  Virology  129, 137-154 (1983).

105.   Young, J. F., Capecchi, M., Laski, F. A., RajBhandary, U. L., Sharp, P. A., and Palese, P.  Measurement of suppressor transfer RNA activity.  Science 221, 873-875 (1983).

106.   Summers, W. P., Summers, W. C., Laski, F. A., RajBhandary, U. L., and Sharp, P. A.  Functional suppression in mammalian cells of nonsense mutations in the herpes simplex virus thymidine kinase gene by suppressor tRNA genes.  J. Virol. 47, 376-379 (1983).

107.   Laski, F. A., Fire, A. Z., RajBhandary, U. L., and Sharp, P. A.  Characterization of tRNA precursor splicing in mammalian extracts.  J. Biol. Chem. 258, 11974-11980 (1983).

108.   Kaufman, R. J., Sharp, P. A., and Latt, S. A.  Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences.  Mol. Cell. Biol. 3, 699-711 (1983).

109.   Berkner, K. L., and Sharp, P. A.  Generation of adenovirus by transfection of plasmids.  Nucleic Acids Res. 11, 6003-6020 (1983).

110.   Kingston, R. E., Kaufman, R. J., and Sharp, P. A.  Regulation of gene expression by the adenoviral EIa region and by c-myc.  In Cancer Cells, Oncogenes and Viral Genes (G. F. Vande Woude, A. J. Levine, W. C. Topp, and J. D. Watson, eds.), Vol. II, pp. 539-544, New York:  Cold Spring Harbor Press (1984).

111.   Hansen, U., and Sharp, P. A.  Sequences controlling in vitro transcription of SV40 promoters.  EMBO J. 2, 2293-2303 (1983).

112.   Hansen, U. and Sharp, P. A.  Transcription by RNA polymerase II.  In Comprehensive Virology (H. Fraenkel-Conrat and R. R. Wagner, eds.), Vol. 19, pp. 65-97, New York:  Plenum Publishing Corp. (1983).

113.   Kaufman, R. J. and Sharp, P. A.  Amplification and regulated expression of a modular dihydrofolate cDNA gene.  In Gene Transfer and Cancer (M. L. Pearson and N. L. Sternberg, eds.), pp. 351-360, New York:  Raven Press (1983).

114.   Manley, J. L., Fire, A., Samuels, M., and Sharp, P. A.  In vitro transcription: whole-cell extract.  Methods in Enzymology 101, 568-582 (1983).

115.   Sharp, P. A.  Adenovirus transcription.  In The Adenoviruses (H. S. Ginsberg, ed.), Chapter 5, pp. 173-204, New York:  Plenum Press Corp. (1984).

116.   Fire, A., Samuels, M., and Sharp, P. A.  Interactions between RNA polymerase II, factors, and template leading to accurate transcription.  J. Biol. Chem. 259, 2509-2516 (1984).

117.   Samuels, M., Fire, A., and Sharp, P. A.  Dinucleotide priming of transcription mediated by RNA polymerase II.  J. Biol. Chem. 259,  2517-2525 (1984).

118.   Padgett, R. A., Mount, S. M., Steitz, J. A., and Sharp, P. A.  Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein.  Cell 35, 101-107 (1983).

119.   Hardy, S. F., Grabowski, P. J., Padgett, R. A., and Sharp, P. A.  Cofactor requirements of splicing of purified messenger RNA precursors.  Nature 308, 375-377 (1984).

120.   Handa, H., and Sharp, P. A.  Requirement for distal upstream sequences for maximal transcription in vitro of early region IV of adenovirus.  Mol. Cell. Biol. 4, 791-798 (1984).

121.   Moore, C. L., and Sharp, P. A.  Site-specific polyadenylation in a cell-free reaction.  Cell 36, 581-591 (1984).

122.   Berkner, K. L., and Sharp, P. A.  Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus.  Nucleic Acids Res. 12, 1925-1941 (1984).

123.   Grabowski, P. J., Padgett, R. A., and Sharp, P. A.  Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate.  Cell 37, 415-427 (1984).

124.   Kingston, R. E., Kaufman, R. J., and Sharp, P. A.  Regulation of transcription of the adenovirus EII promoter by EIa gene products: absence of sequence specificity.  Mol. Cell. Biol. 4, 1970-1977 (1984).

125.   Kingston, R. E., Baldwin, A. S., and Sharp, P. A.  Regulation of heat shock protein 70 gene expression by c-myc.  Nature 312, 280-282 (1984).

126.   Konarska, M. M., Padgett, R. A., and Sharp, P. A.  Recognition of cap structure in splicing in vitro of mRNA precursors.  Cell 38, 731-736.(1984).

127.   Laski, F. A., Belagaje, R., Hudziak, R. M., Capecchi, M. R., Norton, G. P., Palese, P., RajBhandary, U. L., and Sharp, P. A.  Synthesis of an ochre suppressor tRNA gene and expression in mammalian cells.  EMBO J. 3, 2445-2452 (1984).

128.   Padgett, R. A., Konarska, M. M., Grabowski, P. J., Hardy, S. F., and Sharp, P. A.  Lariat RNA’s as intermediates and products in the splicing of messenger RNA precursors.  Science 225, 898-903 (1984).

129.   Sharp, P. A., Hardy, S., and Padgett, R. A.  Splicing of messenger RNA precursors.  In Transfer and Expression of Eukaryotic Genes, Chapter 7, pp. 183-202, Academic Press (1984).

130.   Konarska, M. M., Grabowski, P. J., Padgett, R. A., and Sharp, P. A.  Characterization of the branch site in lariat RNAs produced by splicing of mRNA precursors.  Nature 313, 552-557 (1985).

131.   Capone, J. P., Sharp, P. A., and RajBhandary, U. L.  Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene.  EMBO J. 4, 213-221 (1985).

132.   Berkner, K. L. and Sharp, P. A.  Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant.  Nucleic Acids Res. 13, 841-857 (1985).

133.   Padgett, R. A., Grabowski, P. J., Konarska, M. M., and Sharp, P. A.  Splicing of messenger RNA precursors:  Branch sites and lariat RNAs.  TIBS 10, 154-157 (1985).

134.   Kingston, R. E., Baldwin, A. S., and Sharp, P. A.  Transcription control by oncogenes.  Cell 41, 3-5 (1985).

135.   Sharp, P. A., Kingston, R. E., Baldwin, A. S., Padgett, R. A., Konarska, M. M., and Grabowski, P. J.  Expression of mRNA in eucaryotic cells.  In Molecular Biology of Muscle Development:  UCLA Symp. on Molecular and Cellular Biol., New Series (C. Emerson, D. A. Fischman, B. Nadal-Ginard, and M. A. Q. Siddiqui, eds.), Vol. 29, New York:  Alan R. Liss, Inc. (1985).

136.   Padgett, R. A., Konarska, M. M., Grabowski, P. J., Aebi, M.,  Weissmann, C., and Sharp, P. A.  Studies on the mechanism of mRNA splicing in vitro.  In Sequence Specificity in Transcription and Translation: UCLA Symposia on Molecular and Cellular Biol., New Series (C. Emerson, D. A. Fischman, B. Nadal-Ginard, and M. A. Q. Siddiqui, eds.), Vol. 30, New York:  Alan R. Liss, Inc. (1985).

137.   Moore, C. L. and Sharp, P. A.  Accurate cleavage and polyadenylation of exogenous RNA substrate.  Cell 41, 845-855 (1985).

138.   Grabowski, P. J., Seiler, S. R., and Sharp, P. A.  A multicomponent complex is involved in the splicing of messenger RNA precursors.  Cell 42, 345-353 (1985).

139.   Konarska, M. M., Padgett, R. A., and Sharp, P. A.  Transsplicing of mRNA precursors in vitro.  Cell 42, 165-171 (1985).

140.   Jat, P. S. and Sharp, P. A.  Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts.  J. Virol. 59, 746-750 (1986).

141.   Samuels, M. and Sharp, P. A.  Purification and characterization of a specific RNA polymerase II transcription factor.  J. Biol. Chem. 261, 2003-2013 (1986).

142.   Sharp, P. A.  On the origin of RNA splicing and introns.  Cell 42, 397-400 (1985).

143.   Padgett, R. A., Konarska, M. M., Aebi, M., Hornig, H., Weissmann, C., and Sharp, P. A.  Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit b-globin genes.  Proc. Natl. Acad. Sci. USA 82, 8349-8353 (1985).

144.   Carthew, R. W., Chodosh, L. A., and Sharp, P. A.  An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter.  Cell 43, 439-448 (1985).

145.   Jat, P. S., Cepko, C. L., Mulligan, R. C., and Sharp, P. A.  Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens.  Mol. Cell. Biol. 6, 1204-1217 (1986).

146.   Singh, H., Sen, R., Baltimore, D., and Sharp, P. A.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.  Nature 319, 154-158 (1986).

147.   Padgett, R. A., Grabowski, P. J., Konarska, M. M., Seiler, S., and Sharp, P. A.  Splicing of messenger RNA precursors.  Annu. Rev. Biochem. 55, 1119-1150 (1986).

148.   Choi, Y. D., Grabowski, P. J., Sharp, P. A., and Dreyfuss, G.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.  Science 231, 1534-1539 (1986).

149.   Sharp, P. A.  Analysis of splicing of mRNA precursors in vitro.  In Cancer Cells 4 / DNA Tumor Viruses pp. 245-248, Cold Spring Harbor Laboratory (1986). 

150.   Weinberger, J., Baltimore, D. and Sharp, P. A.  Distinct factors bind to apparently homologous sequences in the immunoglobulin heavy chain enhancer.  Nature 322, 846-848 (1986).

151.   Moore, C. L., Skolnik-David, H. and Sharp, P. A.  Analysis of RNA cleavage at the adenovirus-2 L3 polyadenylation site.  EMBO J. 5, 1929-1938 (1986).

152.   Konarska, M. and Sharp, P. A.  Electrohoretic separation of complexes involved in the splicing of precursors to mRNAs.  Cell 46, 845-855 (1986).

153.   Grabowski, P. J. and Sharp, P. A.  Affinity chromatography of splicing complexes:  U2, U5 and U4+U6 small nuclear ribonucleoprotein particles in the spliceosome.  Science 233, 1294-1299 (1986).

154.   Sharp, P. A.  Splicing of messenger RNA precursors.  The Harvey Lectures, Series 81, Alan R. Liss Publishers, pp. 1-31 (1987).

155.   Capone, J. P., Sedivy, J. M., Sharp, P. A. and RajBhandary, U. L.  Introduction of UAG, UAA, and UGA nonsense mutations at a specific site in the Escherichia coli chloramphenicol acetyltransferase gene:  Use in measurement of amber, ochre, and opal suppression in mammalian cells.  Mol. Cell. Biol. 6, 3059-3067 (1986).

156.   Staudt, L. M., Singh, H., Sen, R., Wirth, T., Sharp, P. A. and Baltimore, D.  A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes.  Nature 323, 640-643 (1986).

157.   Berkner, K. L., Schaffhausen, B. S., Roberts, T. M. and Sharp, P. A.  Abundant expression of the polyoma middle T antigen and of dihydrofolate reductase in an adenovirus recombinant.  J. Virol. 61, 1213-1220 (1987).

158.   Chodosh, L. A., Carthew, R. W. and Sharp, P. A.  A single polypeptide possesses the binding and transcription activities of the major late transcription factor of adenovirus.  Mol. Cell. Biol. 6, 4723-4733 (1986).

159.   Baldwin, A. S., Jr., and Sharp, P. A.  Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.  Mol. Cell. Biol. 7, 305-313 (1987).

160.   Sharp, P. A.  Splicing of messenger RNA precursors.  Science 235, 766-771 (1987).

161.   Sharp, P. A., Carthew, R. W. and Chodosh, L. A.  Sequence-specific DNA binding proteins and transcription in mammalian cells.  In RNA Polymerase and the Regulation of Transcription (Reznikoff et al., eds.), Elsevier Science Publishing Co., Inc. pp. 313-322 (1987).

162.   Konarska, M. M. and Sharp, P. A.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.  Cell 49, 763-774 (1987).

163.   Sedivy, J. M., Capone, J. P., RajBhandary, U. L. and Sharp, P. A.  An inducible mammalian amber suppressor:  Propagation of a poliovirus mutant.  Cell 50, 379-389 (1987).

164.   Hanaka, S., Nichigaki, T., Sharp, P. A. and Handa, H.  Regulation of in vitro and in vivo transcription of early region IV of adenovirus type 5 by multiple cis-acting elements.  Mol. Cell. Biol. 7, 2578-2587 (1987).

165.   Lamond, A. I., Konarska, M. M. and Sharp, P. A.  A mutational analysis of spliceosome assembly:  Evidence for splice site collaboration.  Genes Dev. 1, 532-543 (1987).

166.   Sharp, P. A.  Transsplicing:  Variation on a familiar theme?  Cell (Minireview) 50, 147-148 (1987).

167.   Skolnik-David, H., Moore, C. L. and Sharp, P. A.  Electrophoretic separation of polyadenylation-specific complexes.  Genes Dev. 1, 672-682 (1987).

168.   Moore, C. L., Skolnik-David, H. and Sharp, P. A.  Sedimentation analysis of polyadenylation-specific complexes.  Mol. Cell. Biol. 8, 226-233 (1988).

169.   Carthew, R. W., Chodosh, L. A. and Sharp, P. A.  The major late transcription factor binds to and activates   the mouse metallothionine I promoter.  Genes Dev. 1, 973-980 (1987).

170.   Chodosh, L. A., Carthew, R. W., Morgan, J. W., Crabtree, G. R. and Sharp, P. A.  An adenovirus major late transcription factor activates the rat g-fibrinogen promoter.  Science 238, 684-688 (1987).

171.   Baldwin, A. S., Jr., and Sharp, P. A.  Two transcription factors, NF-kB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.  Proc. Natl. Acad. Sci. USA 85, 723-727 (1988).

172.   Ganguly, S., Sharp, P. A. and RajBhandary, U. L.  Saccharomyces cerevisiae Sup53 tRNA gene transcripts   are processed by mammalian cell extracts in vitro but are not processed in vivo.  Mol. Cell. Biol. 8, 361-370 (1988).

173.   Weinberger, J., Jat, P., and Sharp, P. A.  Localization of a repressive sequence contributing to B-cell specificity in the immunoglobulin heavy chain enhancer.  Mol. Cell. Biol. 8, 988-992 (1988).

174.   Lamond, A. I., Konarska, M. M., Grabowski, P. J. and Sharp, P. A.  Spliceosome assembly involves the binding and release of U4 snRNP.  Proc. Natl. Acad. Sci. USA 85, 411-415 (1988).

175.   Singh, H., LeBowitz, J. H., Baldwin, A. S., Jr., and Sharp, P. A.  Molecular cloning of an enhancer binding protein:  Isolation by screening of an expression library with a recognition site DNA.  Cell 52, 415-423 (1988).

176.   Sharp, P. A. and Eisenberg, D.  The evolution of catalytic function (Perspective).  Science 238, 729 (1987).

177.   Sharp, P. A., Konarska, M. M., Grabowski, P. J., Lamond, A. I., Marciniak, R. and Seiler, S.  Splicing of messenger RNA precursors.  Cold Spring Harbor Symp. Quant. Biol., Vol. 52, #71 (1987).

178.   Virtanen, A. and Sharp, P. A.  Processing at immunoglobulin polyadenylation sites in lymphoid cell extracts.  EMBO J. 7, 1421-1429 (1988).

179.   Chodosh, L. A., Baldwin, A. S., Carthew, R. W. and Sharp, P. A.  Human CCAAT-binding proteins have heterologous subunits.  Cell 53, 11-24 (1988).

180.   Chodosh, L. A., Olesen, J., Hahn, S., Baldwin, A. S., Guarente, L. and Sharp, P. A.  A yeast and a human CCAAT-binding proteins have heterologous subunits that are functionally interchangeable.  Cell 53, 25-35 (1988).

181.   Buratowski, S., Hahn, S., Sharp, P. A. and Guarente, L.  Function of a yeast TATA element-binding protein in a mammalian transcription system.  Nature 334, 37-42 (1988).

182.   Staudt, L. M., Clerc, R. G., Singh, H., LeBowitz, J., Sharp, P. A. and Baltimore, D.  Molecular cloning of a lymphoid-specific cDNA encoding a protein that binds to the regulatory octamer motif.  Science 241, 577-580 (1988).

183.   Konarska, M. M. and Sharp, P. A.  Association of U2, U4, U5, and U6 small nuclear ribonucleoproteins in a spliceosome-type complex in absence of precursor RNA.  Proc. Natl. Acad. Sci. USA 85, 5459-5462 (1988).

184.   LeBowitz, J. H., Kobayashi, T., Staudt, L., Baltimore, D., and Sharp, P. A.  Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy chain promoter in vitro.  Genes Dev. 2, 1227-1237 (1988).

185.   Carthew, R. W., Samuels, M. and Sharp, P. A.  Formation of transcription preinitiation complexes with an amanitin-resistant RNA polymerase II.  J. Biol. Chem. 263, 17128-17135 (1988).

186.   Sharp, P. A.  RNA splicing and genes.  (Based on a lecture given at the presentation of the Albert Lasker Basic Medical Research Award, New York, Nov. 18, 1988).  JAMA 260, 3035-3041 (1988).

187.   Clerc, R. G., Corcoran, L. M., LeBowitz, J. H., Baltimore, D. and Sharp, P. A.  The B-cell specific Oct-2 protein contains POU box- and homeo box-type domains.  Genes Dev. 2, 1570-1581 (1988).

Herr, W., Sturm, R. A., Clerc, R. G., Corcoran, L. M., Baltimore, D., Sharp, P. A., Ingraham, H. A., Rosenfeld, M. G., Finney, M., Ruvkun, G., and Horvitz, H. R.  The POU domain:  a large conserved region of the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products.  LETTER TO THE EDITOR:  Genes Dev. 2, 1513-1516 (1988)

188.   Sharp, P. A. and Konarska, M. M.  The biology of splicing of precursors to mRNAs.  Bristol-Myers Symposia (1988).   

188a.  Shapiro, D. J., Sharp, P. A., Wahli, W. W., and Keller, M. J.  Laboratory methods:  A high-efficiency HeLa cell nuclear transcription extract.  DNA 7, 47-55 (1988).

189.   Chodosh, L. A., Fire, A., Samuels, M. and Sharp, P. A.  5,6-Dichloro-1-b-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro.  J. Biol. Chem. 264, 2250-2257 (1989).

190.   Sedivy, J. M. and Sharp, P. A.  Positive genetic selection for gene disruption in mammalian cells by homologous recombination.  Proc. Natl. Acad. Sci. USA 86, 227-231 (1989).

191.   Buratowski, S., Hahn, S., Guarente, L. and Sharp, P. A. Five intermediate complexes in transcription initiation by RNA polymerase II.  Cell 56, 549-561 (1989).

192.   Blanar, M. A., Baldwin, A. S., Flavell, R. A. and Sharp, P. A.  Induction by interferon of a transcriptional factor regulating the major histocompatibility complex class I genes.  EMBO J. 8, 1139-1144  (1989).

193.  Chodosh, L. A., Buratowski, S. and Sharp, P. A.  A yeast protein possesses the DNA binding properties of the adenovirus major late transcription factor.  Mol. Cell. Biol. 9, 820-822 (1989).

194.   Jat, P. S. and Sharp, P. A.  Cell lines established by a temperature-sensitive SV40 large T antigen gene are growth restricted at the nonpermissive temperature.  Mol. Cell. Biol. 9, 1672-1681  (1989).

195.   Garcia-Blanco, M. A., Clerc, R. G. and Sharp, P. A.  The DNA binding homeodomain of the Oct-2 protein:  A  commentary.  Genes Dev. 3, 739-745 (1989).

196.   Konarska, M. M. and Sharp, P. A.  Replication of RNA by the DNA-dependent RNA polymerase of phage T7.  Cell 57, 423-431 (1989).

197.   Sharp, P. A.  Gene regulation and oncogenes:  Meeting Report of the AACR Special Conference in Cancer Research.  Cancer Research 49, 2188-2194 (1989). 

198.   Hahn, S., Buratowski, S., Sharp, P. A., and Guarente, L.  Yeast TATA binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences.  Proc. Natl. Acad. Sci. USA 86, 5718-5722 (1989).

199.   LeBowitz, J. H., Clerc, R. G., Brenowitz, M., and Sharp, P. A.  The Oct-2 protein binds cooperatively to adjacent octamer sites.  Genes Dev. 3, 1625-1638 (1989).

200.   Hahn, S., Buratowski, S., Sharp, P. A., and Guarente, L.  Isolation of the gene encoding the yeast   TATA-binding protein TFIID:  A gene identical to the SPT15 suppressor of TY element insertions.  Cell 58, 1173-1181 (1989).

201.   Sharp, P. A. and Marciniak, R. A.  HIV TAR:  An RNA enhancer?  Cell (minireview) 59, 229-230 (1989).

202.   Hahn, S., Buratowski, S., Sharp, P. A., and Guarente, L.  Identification of a yeast protein homologous in function to the mammalian general transcription factor TFIIA.  EMBO J. 8, 3379-3382 (1989).

203.   Schnipper, L. E., Chan, V., Sedivy, J., Jat, P., and Sharp, P. A.  Gene activation by induced DNA rearrangements.  Cancer Research 49, 6640-6644 (1989).

204.   Kristie, T. M., LeBowitz, J. H., and Sharp, P. A.  The octamer-binding proteins from multi-protein-DNA complexes with the HSV aTIF regulatory protein.  EMBO J. 8, 4229-4238 (1989).

205.   Chang, D. and Sharp, P. A.  Regulation by HIV rev depends upon recognition of splice sites.  Cell 59, 789-795 (1989).

206.   Laski, F. A., Ganguly, S., Sharp, P. A., RajBhandary, U. L., and Rubin, G. M.  Construction, stable transformation, and function of an amber suppressor gene in Drosophila melanogaster.   Proc. Natl. Acad. Sci. USA 86, 6696-6698 (1989).

207.   Manley, N. R., O’Connell, M. A., Sharp, P. A., and Hopkins, N.  Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.  J. Virol. 63, 4210-4223 (1989).

208.   Garcia-Blanco, M. A., Jamison, S. F., and Sharp, P. A.  Identification and purification of a 62,000 dalton protein which binds specifically to the polypyrimidine tract of introns.  Genes Dev. 3, 1874-1886 (1989).

209.   Baldwin, A. S., LeClair, K. P., Singh, H., and Sharp, P. A.  A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and k immunoglobulin genes.  Mol. Cell. Biol. 10, 1406-1414 (1990).

210.   Garcia-Blanco, M. A., Anderson, G. J., Beggs, J. D., and Sharp, P. A.  A 220,000 dalton mammalian protein binds precursor messenger RNAs in the spliceosome:  A putative homologue of the yeast PRP8 protein.  Proc. Natl. Acad. Sci. USA 87, 3082-3086 (1990).

211.   Marciniak, R. A., Garcia-Blanco, M. A., and Sharp, P. A.  Identification and characterization of a HeLa nuclear protein that specifically binds to the TAR element of HIV.  Proc. Natl. Acad. Sci. USA 87, 3624-3628 (1990).

212.   Brown, M. and Sharp, P. A.  Human estrogen receptor forms multiple protein-DNA complexes.  J. Biol. Chem. 265, 11238-11243 (1990).

213.   Carr, C. and Sharp, P. A.  A helix-loop-helix  protein related to the immunoglobulin E box binding proteins.  Mol. Cell. Biol. (Note) 10, 4384-4388 (1990).

214.   Chang, D. and Sharp, P. A.  Messenger RNA transport and HIV rev regulation.  Science (review article) 249, 614-615 (1990).

215    Buratowski, S. and Sharp, P. A.  Transcription initiation complexes and upstream activation with RNA polymerase II lacking the largest subunit c-terminal domain.  Mol. Cell. Biol. (Note) 10, 5562-5564 (1990).

216.   Sharp, P. A. and Buratwoski, S.  Regulation of Transcription.  In Bristol-Myers Symposium on “Molecular Mechanisms and their Clinical Application in Malignancies”, Vol. 12, D. E. Bergsagel and T. W. Mak, eds., Academic Press, Inc. publishers, pp. 109-124 (1991).

217.   Marciniak, R. A., Calnan, B. J., Frankel, A. D. and Sharp, P. A.  HIV-1 Tat protein transactivates transcription in vitro.  Cell 63, 791-802 (1990).

218.   Konarska, M. M. and Sharp, P. A.  Structural features of RNAs replicated by the DNA-dependent RNA polymerase of phage T7.  Cell 63, 609-618 (1990).

219.   Kristie, T. M. and Sharp, P. A.  Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV a-transactivator protein.  Genes Dev. 4, 2383-2396 (1990).

220.   Kjems, J., Brown, M., Chang, D. D., and Sharp, P. A.  Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.  Proc. Natl. Acad. Sci. USA 88, 683-687 (1991).

221.   Buratowski, S. and Sharp, P. A.  Initiation of transcription by RNA polymerase II. Cold Spring Harbor monograph on Transcription Regulation, S.L. McKnight and K. R. Yamamoto, eds., Cold Spring Harbor Press (1991).

222.   Sharp, P. A., Marciniak, R. A., Frankel, A. D. and Kjems, J.  Mechanisms of regulation by tat and rev.  In:  Genetic Structure and Regulation of HIV book based on a conference of the Harvard Aids Institute.  W. A. Haseltine and F. Wong-Staal, eds., Raven Press, New York (1991).

223.    Sharp, P. A.  TFIIB or not TFIIB?  Nature (News and Views) 351, 16-18 (1991).

224.   Flanagan, J. R., Murata, M., Burke, P. A., Shirayoshi, Y., Appella, E., Sharp, P. A. and Ozato, K.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.  Proc. Natl. Acad. Sci. USA 88, 3145-3149 (1991).

225.   Buckler, A., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A. and Housman, D. E.  Exon amplification:  A strategy to isolate mammalian genes based on RNA splicing.  Proc. Natl. Acad. Sci. USA 88, 4005-4009 (1991).

226.   Gil, A., Sharp, P. A., Jamison, S. F. and Garcia-Blanco, M. A.  Characterization of cDNAs encoding the polypyrimidine tract-binding proteins.  Genes Dev. 5, 1224-1236 (1991).

227.   Zhang, Y., Babin, J., Feldhaus, A. L., Singh, H., Sharp, P. A. and Bina, M.  HTF4: A new human helix-loop-helix protein related to the Drosophila Daughterless.  Nucleic Acids Res. 19, 4555 (1991).

228.   Buratowski, S., Sopta, M., Greenblatt, J. and Sharp, P. A.  RNA polymerase II associated proteins induced a DNA conformation change in the  initiation complex.  Proc. Natl. Acad. Sci. USA 88, 7509-7513 (1991).

229.   Kjems, J., Frankel, A. D., and Sharp, P. A. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.  Cell 67, 169-178 (1991).

230.   Sharp, P. A.  “Five Easy Pieces”, Science (perspective) 254, 663 (1991).

231.   Timmers, H.Th.M. and Sharp, P. A.   The mammalian TFIID protein is present in two functionally distinct complexes.  Genes & Dev. 5, 1946-1956 (1991).

232.   Fisher, D. E., Carr, C. S., Parent, L. A. & Sharp, P. A.  TFEB has DNA binding and oligomerication properties.  Genes & Dev. 5, 2342-2352 (1991).

233.   Marciniak, R. A. and Sharp, P. A.  HIV-1 Tat protein promotes formation of more-processive elongation complexes.  EMBO J. 10, 4189-4196 (1991).

234.   Parvin, J. D. and Sharp, P. A.  Identification of novel factors which bind specifically to the core promoter of the immunoglobulin heavy chain gene.  J. Biol. Chem. 266, 22878-22886 (1991).

235.   Sharp, P. A.  Regulation of transcription and oncogenic transformation.  In Origins of Human Cancer, J. Brugge, T. Curran, E. Harlow, and F. McCormick, eds., Cold Spring Harbor Laboratory Press, pp. 335-343 (1991).

236.   Kjems, J., Calnan, B. J., Frankel, A. D., and Sharp, P. A. Specific binding of a basic peptide from HIV-1 Rev.  EMBO J. 11, 1119-1129 (1992).

237.   Sharp, P. A.  TATA-binding protein is a classless factor.  Cell (Minireview) 68, 819-821 (1992).

238.   Parvin, J. D., Timmers, H.Th. M., and Sharp, P. A.  Promoter specificity of basal transcription factors.  Cell 68, 1135-1144 (1992).

239.   Moore, M. and Sharp, P. A.  Site-specific modification of pre-mRNA:  the 2’-hydroxyl groups at the splice sites.  Science 256, 992-997 (1992).

240.   Haber, D. A., Timmers, H.Th. M., Pelletier, J. , Sharp , P. A. and Housman, D. E.   A dominant mutation in the Wilm’s tumor gene WT1 cooperates with E1A in transforming primary kidney cells.  Proc. Natl. Acad. Sci. USA 89, 6010-6014 (1992).

241.   Timmers, H.Th. M., Meyers, R. E., and Sharp, P. A.  Composition of the transcription factor B-TFIID.  Proc. Natl. Acad. Sci. USA 89, 8140-8144 (1992).

242.   LeClair, K., Blanar, M., and Sharp, P. A.  The p50 subunit of NF-kB associates with the NF-IL6 transcription factor.  Proc. Natl. Acad. Sci. USA 89, 8145-8149(1992).

243.   Pomerantz, J. L., Kristie, T. M., and Sharp, P. A.  Recognition of the surface of a homeodomain protein.  Genes Dev. 6, 2047-2057 (1992).

244.   Fisher, D. E., Parent, L. A., and Sharp, P. A.  Myc/Max and other helix-loop-helix/leucine-zipper proteins bend DNA towards the minor groove.  Proc. Natl. Acad. Sci. USA 89, 11779-11783 (1992).

245.   Fisher, D. E., Parent, L. A., and Sharp, P. A.  High affinity DNA binding Myc analogs:  Recognition by an a helix.  Cell 72, 467-476 (1993).

246.   Kristie, T. and Sharp, P. A.  Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus a trans-induction factor (VP16).  J. Biol. Chem. 268, 6525-6534 (1993).

247.   Parvin, J. D. and Sharp, P. A.  DNA topology and a minimal set of basal factors for transcription by RNA polymerase II. Cell 73, 533-540 (1993).

248.   Kjems, J. and Sharp, P. A.  The basic domain of Rev from HIV-1 specifically blocks the entry of U4/6-U5 snRNP in spliceosome assembly.  J. Virol. 67, 4769-4776 (1993).

249.   Potter, D. A., Larson, C. J., Eckes, P., Schmid, R. M., Nabel, G. J., Verdine, G. L., and Sharp, P. A.  Purification of the MHC class I transcription factor H2TF1:  the full-length product of the nfkb2 gene.  J. Biol. Chem. 268, 18882-18890 (1993).

250.   Moore, M. J., Query, C. C., and Sharp, P. A.  Splicing of precursors to messenger RNAs by the spliceosome.  In The RNA World, R. Gesteland and J. Atkins, eds., Cold Spring Harbor Laboratory Press, pp. 303-357 (1993).

251.   Chasman, D. I., Flaherty, K. M., Sharp, P. A., and Kornberg, R. D.  Crystal structure of yeast TATA-binding protein and model for interaction with DNA.  Proc. Natl. Acad. Sci. USA 90, 8174-8178 (1993).

252.   Moore, M. J. and Sharp, P. A.  The stereochemistry of pre-mRNA splicing:  evidence for two active sites in the spliceosome.  Nature 365, 364-368 (1993).

253.   Srebrow, A., Muro, A. F., Werbajh, S., Sharp, P. A. and Kornblihtt, A. R.  The CRE-binding factor ATF-2 facilitates the occupation of the CCAAT box in the fibronectin gene promoter.  FEBS Letters 327, 25-28 (1993).

254.   Meyers, R. E. and Sharp, P. A.  TATA-binding protein and associated factors in polymerase II and polymerase III transcription.  Mol. Cell. Biol. 13, 7953-7960 (1993).

255.   Aird, W. C., Parvin, J. D., Sharp, P. A., and Rosenberg, R. D.  The interaction of GATA-binding proteins and basal transcription factors with GATA box-containing core promoters:  a model of tissue specific gene expression.  J. Biol. Chem. 269, 883-889 (1994).

256.   Query, C. C., Moore, M. J. and Sharp, P. A.  Branch nucleophile selection in pre-mRNA splicing:  Evidence for the bulged duplex model.  Genes Dev. 8, 587-597 (1994).

257.   Parvin, J. D., Shykind, B. M., Meyers, R. E., Kim, J. and Sharp, P. A.  Multiple sets of basal factors initiate transcription by RNA polymerase II.  J. Biol. Chem. 269, 18414-18421 (1994).

258.    Sharp, P. A.  Split genes and RNA splicing (Nobel Lecture).  Cell 77, 805-815 (1994)

259.   Sharp, P. A.  Split Genes and RNA Splicing Nobel Lecture, pp. 162-193.  1993 Les Prix Nobel.  Published by the Nobel Foundation (1994).

260.   Crispino, J., Blencowe, B. J. and Sharp, P. A.  Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP.  Science 265, 1860-1869 (1994).

261.   Pomerantz, J. L. and Sharp, P. A.  Homeodomain determinants of major groove recognition.  Biochemistry 33, 10851-10858 (1994).

262.   Blencowe, B. J., Nickerson, J.A., Issner, R., Penman, S. & Sharp, P. A.  Association of nuclear matrix antigens with exon-containing splicing complexes.  J. Cell Biol. 127, 593-607 (1994).

263.   MacMillan, A. M., Query, C. C., Allerson, C. R., Chen, S., Verdine, G. L., and Sharp, P. A. Dynamic association of proteins with the pre-mRNA branch region.  Genes Dev. 8, 3008-3020 (1994).

264.   Zhou, Q. and Sharp, P. A.  Novel mechanism and factor for regulation by HIV-1 Tat.  EMBO J. 14, 321-328 (1995).

265.   Pomerantz, J. L., Sharp, P. A., and Pabo, C. O.  Structure-based design of transcription factors.  Science 267, 93-96 (1995).

266.   Kristie, T. M., Pomerantz, J. L., Twomey, T. C., Parent, S. A., and Sharp, P. A.  The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides.  J. Biol. Chem. 270, 4387-4394 (1995).

267.   Parvin, J. D., McCormick, R. J., Sharp, P. A., and Fisher, D. E.  Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor.  Nature 373, 724-727 (1995).

268.   Mäkelä, T. P., Parvin, J. D., Kim, J., Huber, L. J., Sharp, P. A., and Weinberg, R. A.  A kinase-deficient transcription factor IIH is functional in basal and activated transcription.  Proc. Natl. Acad. Sci. USA 92, 5174-5178 (1995).

269.   Shykind, B., Kim, J., and Sharp, P. A.  Activation of the TFIID-TFIIA complex with HMG-2.  Genes Dev. 9, 1354-1365 (1995).

270.   Crispino, J. and Sharp, P.A.  A U6 snRNA: pre-mRNA interaction can be rate-limiting for U1-independent splicing.  Genes Dev. 9, 2314-2323 (1995).

271.   Pomerantz, J. L., Pabo, C. O., and Sharp, P. A.  Analysis of homeodomain function by structure-based design of a transcription factor.  Proc. Natl. Acad. Sci. USA 92, 9752-9756 (1995).

272.   Blencowe, B. J., Issner, R., Kim, J., McCaw, P., and Sharp, P. A.  New proteins related to the Ser-Arg family of splicing factors. RNA 1, 852-865  (1995).

273.   Query, C. C., Strobel, S. A., and Sharp, P. A.  Three recognition events at the branch site adenine.  EMBO J. 15, 1392-1402 (1996).

274.   Crispino, J. D., Mermoud, J., Lamond, A., and Sharp, P. A.  Cis-acting elements from the 5’ splice site promote U1-independent pre-mRNA splicing.  RNA 2, 664-673 (1996).

275.   Kim, J., Parvin, J.D., Shykind, B.M., and Sharp, P.A. A negative cofactor containing Dr1/p19 modulates transcription with TFIIA in a promoter specific fashion.  J. Biol. Chem. 271, 18405-18412 (1996).

276.   Harper, S.E., Qiu, Y., and Sharp, P.A. Sin3 corepressor function in myc-induced transcription and transformation. Proc. Natl. Acad. Sci. USA 93, 8536-8540 (1996).

277.   Mortillaro, M.J., Blencowe, B.J., Wei, X., Nakayasu, H., Du, L., Warren, S.L., Sharp, P.A. and Berezney, R.  A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix.  Proc. Natl. Acad. Sci. USA 93, 8253-8257 (1996).

278.   Cepek, K.L., Chasman, D.I., and Sharp, P.A. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.  Genes Dev. 10, 2079-2088 (1996).

279.   Zhou, Q. and Sharp, P. A.  Tat-SF1:  Cofactor for stimulation of transcriptional elongation by HIV-1 Tat.  Science 274, 605-610 (1996).

280.    MacMillan, A. M., McCaw, P. S., Crispino, J.D., and Sharp, P. A.  SC35-mediated reconstitution of splicing in U2AF-depleted nuclear extract.  Proc. Natl. Acad. Sci. USA 94, 133-136 (1997).

281.   Shykind, B. M., Kim, J., Stewart, L., Champoux, J. and Sharp, P.A.  Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.  Genes Dev. 11, 397-407 (1997).

282.   Kim, J.-S., Kim, J., Cepek, K.L., Sharp, P.A., and Pabo, C.O.  Design of TATA-box binding protein/zinc finger fusions for targeted regulation of gene expression.  Proc. Natl. Acad. Sci. USA 94, 3616-3620 (1997).

283.   Query, C. C., McCaw, P. S. and Sharp, P.A.  A minimal spliceosomal A complex recognizes branch site and polypyrimidine tracts.  Mol. Cell. Biol. 17, 2944-2953 (1997).

284.   Jones, G. and Sharp, P.A.  Ultraspiracle:  an invertebrate nuclear receptor for juvenile hormone.  Proc. Natl. Acad. Sci. USA  94, 13499-13503 (1997).

285.    Sharp, P. A. and Burge, C. B.   Classification of introns:  U2-type or U12-type.  Cell (Minireview) 91, 875-879 (1997).

286.   Blencowe, B.J., Issner, R., Nickerson, J., and Sharp, P.A.  A coactivator of pre-mRNA splicing.  Genes Dev.  12, 996-1009 (1998).

287.    Tuschl, T., Sharp, P.A., and Bartel, D.P.  Selection in vitro of novel ribozymes from a partially randomized U2 and U6 snRNA library.  EMBO J. 17, 2637-2650 (1998).

288.   Lim, L. P. and Sharp, P. A.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.  Mol. Cell. Biol. 18, 3900-3906 (1998).

289.   Burge, C., Padgett, R., and Sharp, P.A.  Evolutionary fates and origins of U12-type introns.  Mol. Cell 2, 773-785  (1998).

290.    Burge, C., Tuschl, T. and Sharp, P.A.  Splicing of precursors to mRNAs by the spliceosomes.  In RNA World II, R. Gesteland, T. Cech, and J. Atkins, eds., Cold Spring Harbor Laboratory Press, NY. pp. 525-560 (1999).

291.   Sharp, P.A.  RNAi and double strand RNA.  Genes Dev. (Perspective) 13, 139-141 (1999).

292.   Eldridge, A., Li, Y., Sharp, P. A., and Blencowe, B.  The SRm160/300 splicing coactivator is required for exon-enhancer function.  Proc. Natl. Acad. Sci. USA 96, 6125-6130(1999).

293.   Mitsui, A. and Sharp, P.A.  Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain.  Proc. Natl. Acad. Sci. USA 96, 6054-6059 (1999).

294.   Kim, J.B., Yamaguchi, Y., Wada, T., Handa, H., and Sharp, P.A.  Tat-SF1 protein associates with RAP30 and hSPT5 proteins.  Mol. Cell Biol. 19, 5960-5968 (1999).

295.   Tang, H. and Sharp, P.A. Transcriptional regulation of the murine 3’ IgH enhancer by phosphorylated Oct-2.  Immunity 11, 517-526 (1999).

296.   Gilbert, S. and Sharp, P.A.  Targeted deacetylation of promoter regions of X-inactivated genes.  Proc. Natl. Acad. Sci. USA 96, 13825-13830 (1999).

297.   Tuschl, T., Zamore, P.D., Lehmann, R., Bartel, D.P. and Sharp, P.A.  Targeted mRNA degradation by double-stranded RNA in vitro.  Genes Dev. 13, 3191-3197 (1999).

298.   McCaw, P., Amonlirdviman, K., and Sharp, P.A.  A novel U2AF65-related splicing activity.  RNA 5, 1548-1560 (1999).

299.   Chasman, D., Cepek, K., Sharp, P.A., and Pabo, C.O.  Crystal structure of a ternary complex containing an OCA-B peptide, Oct-1, and an octamer element:  Peptide recognition of a protein-DNA interface.  Genes Dev.  13, 2650-2657 (1999).

300.   Blencowe, B.J., Baurén, G., Issner, R., Eldridge, A., Li, Y., Reifenberg, E., and Sharp, P.A.  The SRm160/300 splicing coactivator subunits.  RNA 6, 111-120 (1999).

Sharp, P.A.  View of life sciences in the 21st century.  J. Dermatological Sci. 24, Suppl. 1, S1-S14 (2000).

301.    Sharp, P.A. and Zamore, P.D.  RNA interference (RNAi).  Science (Perspective) 287, 2431-2432  (2000).

302.   Zamore, P.D., Tuschl, T. , Sharp, P.A., and Bartel, D.P.  RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.  Cell 101, 25-33 (2000).

303.   Scarr, R., Smith, M., Beddall, M., and Sharp, P.A.  A unique 50-kilodalton fragment of host cell factor 1 (C1)  in Go cells.  Mol. Cell. Biol. 20, 3568-3575 (2000).

304.   Gilbert, S., Pehrson, J. and Sharp, P.A.  Xist RNA is a component of the inactive X chromatin.  J. Biol. Chem. 275, 36491-36494  (2000).

305.   Tuschl, T., Sharp, P.A. and Bartel, D.P.  A ribozyme selected from variants of U6 snRNA promotes 2’,5’-branch formation.  RNA 7, 29-43 (2001).

306.   Kim, J.B. and Sharp, P.A. Positive Transcription Elongation Factor b Phosphorylates hSPT5 and RNA Polymerase II Carboxyl-terminal Domain Independently of Cyclin-dependent Kinase-activating Kinase.  J. Biol. Chem. 276, 12317-12323 (2001).

307.   Sharp, P.A.  RNA interference – 2001.  Genes Dev. (Review) 15, 485-490 (2001).

308.   Tantin, D. and Sharp, P.A.  A mouse lympoid cell line selected to have high immunoglobulin promoter activity.  Mol. Cell. Biol. 22, 1460-1473 (2002).

309.   Lee, K.-B., Wang, D., Lippard, S.J., and Sharp, P.A.  Transcription-coupled and DNA damage-dependent  ubiquitination of RNA polymerase II.  Proc. Natl. Acad. Sci. USA 99, 4239-4244 (2002).

310.   McManus, M.T., Petersen, C.P., Haines, B., Chen, J., and Sharp, P.A.  Gene Silencing using micro-RNA designed hairpins.  RNA 8, 842-850 (2002).

311.   Novina, C., Murray, M., Dykxhoorn, D., Beresford, P.J., Riess, J., Collman, R.G., Lieberman, J., Shankar, P., and Sharp, P.A.  siRNA-directed inhibition of HIV infection.  Nature Medicine 8, 681 - 686 (2002).

312.   Fairbrother, W.G., Yeh, R.-F., Sharp, P.A., and Burge, C.B.  Predictive identification of exonic splicing enhancers in human genes.  Science 297, 1007-1013 (2002).

313.   Scarr, R.B. and Sharp, P.A.  PDCD2 is a negative regulator of HCF-1 (C1).  Oncogene 21, 5245-5254 (2002).

314.   McManus, M.T. and Sharp, P.A. Gene Silencing in Mammals by siRNAs. Nature Reviews Genetics 3, 737-747 (2002).

315.   McManus, M.T., Haines, B.B., Dillon, C., Whitehurst, C.E., van Parijs, L., Chen, J., and Sharp, P.A. siRNA-mediated gene silencing in T-lymphocytes.  J. Immunol. 22, 5754-5760 (2002).

316.    Doench, J.G., Peterson, C.P., and Sharp, P.A.  siRNAs can function as miRNAS.  Genes Dev. 17, 438-442 (2003).

317.    Cheng, C. and Sharp, P.A.  RNA polymerase II accumulation in the promoter-proximal region of the dihydrofolate reductase and gamma actin genes.  Mol. Cell. Biol. 23, 1961-1967 (2003).

318.   Stewart, S., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y., An, D.S., Sabatini, D.M., Chen, I. S.Y., Hahn,  W.C., Sharp, P.A., Weinberg, R.A., and Novina, C.D.   Lentivirus-delivered stable gene silencing by RNAi in primary cells.  RNA 9, 493-501 (2003).

319.    Dykxhoorn, D.K., Novina, C.D., and Sharp, P.A.  Killing the messenger: short RNAs that silence     gene expression.  Nature Reviews 4, 457-467 (2003)

320.  Song, E., Lee, S.-K., Dykxhoorn, D. M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P. A., Lieberman, J., Manjunath, N., and Shankar, P.  Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages.  J. Virol. 77, 7174-7181 (2003).

321.    Houbaviy, H. B. and Sharp, P. A.  Embryonic stem cell-specific microRNAs.  Developmental Cell 5, 351-358 (2003).

321.1  Rubinson, D., Dillon, C., Sievers, C., McManus, M. T., Sharp, P.A., Gertler, F., and Van Parijs, L., “Functional and stable gene silencing in mice and primary mammalian cells by lentivirus-mediated RNA interference.   Nature Genetics33, 401-406 (2003).

322.   Ge, Q., McManus, M.T., Nguyen, T., Shen, C.H., Sharp, P.A., Eisen, H.N., Chen, J.  RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription.  Proc. Natl. Acad. Sci USA. 100, 2718-2723 (2003).

323.   Wang, V.E.H., Schmidt, T., Chen, J., Sharp, P.A., and Tantin, D.  E. Embryonic lethality, decreased  erythropoiesis,  and defective octamer-dependent promoter activation in Oct-1-deficient mice.   Mol Cell. Biol. 24, 1022-1032 (2004).

324.   Wang, V.E.H., Tantin, D., Chen, J., and Sharp. P.A.  B-cell development and immunoglobulin    transcription in Oct-1-deficient mice.  Proc. Natl. Acad. Sci., USA 101, 2005-2010 (2004).

325.   Nogueira, M.L., Wang, V.E.H., Tantin, D., Sharp, P.A., and Kristie, T.M.  Herpes virus nfections are arrested in Oct-1 deficient mice.  Proc. Natl. Acad. Sci., USA, 101, 1473-1478 (2004).

326.   Doench, J.G., and Sharp, P.A.  Specificity of microRNA target selection in translational repression. Genes Dev. 18, 504-511 (2004).

327.  Tantin, D., Tussie-Luna, M.I., Roy, A.L., and Sharp, P.A.  Regulation of immunoglobulin promoter activity by TFII-I-class transcription factors.  J. Biol. Chem. 279, 5460 - 5469 (2004).

328.   Novina, C.D. and Sharp, P.A. The RNAi revolution.  Nature (News & Views) 430, 161-164 (2004).       

329.  Ventura, A., Meissner, A., Dillon, C.P., McManus, M., Sharp, P.A., Van Parijs, L., Jaenisch, R., and Jacks, T. Cre-lox regulated conditional RNA interference in cells and mice.  Proc. Natl. Acad. Sci. USA 101, 10380-10385 (2004).

330.   Fairbrother, W.G., Yeo, G.W., Yeh, R., Goldstein, P., Mawson, M., Sharp, P.A., and Burge, C.B.  RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.  Nucleic Acid Res. 32, W1-W4 (2004).

331.   Fairbrother, W.G., Holste, D., Burge, C., and Sharp, P.A. Single nucleotide polymorphism-based validation of exonic splicing enhancers.  PloS Biology 2, e268, pp 1388-1395 (2004).

332.   Mansfield, J.H., Harfe, B.D., Nissen, R., Obenauer, J., Srineel, J., Chaudhuri, A., Farzan-Kashani, R., Zucker, M., Pasquinelli, A.E., Gurkum, G., Sharp, P.A., Tabin, C.J., and McManus, M.  microRNA-responsive “sensor” transgenes  uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression.  Nature Genetics 36, 1079-1083 (2004).

333.   Lee, K. B. and Sharp, P. A. Transcription-dependent polyubiquitination of  RNA Polymerase II requires lysine 63 of ubiquitin.  Biochemistry 43, 15223-15229 (2004).

334.   Grishok, A., Sinskey, J.L., and Sharp, P.A.  Transcription silencing of a transgene  by RNAi in the soma of C. elegansGenes & Dev. 19, 683-696 (2005).

335.  Neilson, J.R. and Sharp, P.A. Herpesviruses throw a curve ball: new insights into microRNA biogenesis and evolution.  Nature Methods  2, 252 - 254 (2005).

336.  Sharp, P.A.  The discovery of split genes and RNA splicing.  Trends in Biochemical Sciences (Editorial) 30, 279-281 (2005)

337.   Houbaviy, H., Dennis, L., Jaenisch, R. and Sharp, P.A. Characterization of a highly variable eutherian microRNA gene.  RNA 11, 1245-1257 (2005)

338.   Hong, J-H, Hwang, E.S., McManus, M.T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegelman, B.M., Sharp, P.A, Hopkins, N., and Yaffe, M.B.  TAZ, A transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078 (2005).

339.   Petersen, C.P., Doench, J.G., Grishok, A., and Sharp, P.A.  The Biology of short RNAs.  In:  RNA World, 3rd edition, R.F. Gesteland, T.R. Cech and J.F. Atkins, editors.  Cold Spring Harbor Laboratory Press, #19, pp. 535-565 (2005).

340.   Miskevich, F., Doench, J., Townsend, M.T., Sharp, P.A., and Constantine-Paton, M. RNA interference of Xenopus NMDAR NR1 in vitro and in vivo.  J. Neuroscience Methods 152, 65-73, 2005.

341.   Grishok, A. and Sharp, P.A.  Negative regulation of nuclear divisions in C. elegans by Rb and RNAi-related genes.  Proc. Natl. Acad. Sci. USA 102, 17360-17365 (2005).

342.  Tantin, D., Schild-Poulter, C., Wang, V.E.H., Haché, R.J., and Sharp, P.A.  The octamer binding transcription factor Oct-1 is a stress sensor.  AACR’s Cancer Research 65. 10750-10758 (2005).

343.   Sharp, P.A.  1918 Flu and responsible science - Editorial. Science 310, 77 (2005).

344.   Cheng C. and Sharp, P.A.  Regulation of CD44 alternative splicing by SRm160 and it’s potential role in tumor cell invasion.  Mol. Cell. Biol. 26, 362-370 (2006).

345.   Petersen, C.P., Bordeleau, M-E., Pelletier, J., and Sharp, P.A.  Short RNAs repress translation after initiation in mammalian cells.  Molecular Cell 21, 1-10 (2006).

346.   Cheng, C., Yaffe, M., and Sharp, P.A.  A positive feedback loop couples Ras activation and CD44 alternative splicing.  Genes Dev. 20, 1715-1720 (2006).

347.   Hakre, S., Tusie-Luna, I., Ashworth, T., Novina, C.D., Settleman, J., Sharp, P.A., and Roy, A.L.  Opposing functions of TFII-1 spliced isoforms in growth factor-induced gene expression.  Mol. Cell 24, 301-308 (2006).

348.  Schild-Poulter, C., Shih, A., Tantin, D., Varymowich, N.C., Soubeyrand, S., Sharp, P.A., and Haché, R.J.G.  DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage.  Oncogene 26, 3980-3988 (2007).

349.   Leung, A.K.L., Calabrese, J.M., and Sharp, P.A.  Quantitative analysis of argonaute protein reveals microRNA-dependent localization to stress granules.  Proc. Natl. Acad. Sci. 103, 18125-18130 (2006).

350.   Calabrese, J.M. and Sharp, P.A.  Characterization of the short RNAs bound by the P19 suppressor of RNA silencing in mouse embryonic stem cells.  RNA 12, 1-11 (2006).

351.  Leung, A. K.L. and Sharp, P.A.  Function and Localization of microRNAs in mammalian cells.  Cold Spring Harbor Symp. Quant. Biol. 71, 29-38 (2006).       

352.   Alemán, LM, Doench, J., and Sharp, P.A.  Comparison of siRNA-induced off-target RNA and protein effects.  RNA 13, 385-395 (2007).

353.   Neilson, J.R., Zheng, G.X.Y., Burge, C.B., and Sharp, P.A.  Dynamic regulation of miRNA expression in ordered stages of cellular development.  Genes Dev. 21, 578-589 (2007).

354.   Wilker, E.W., van Vugt, M.A.T.M., Artim, S.A., Huang, P.H., Petersen, C.P., Reingardt, H.C., Feng, Y., Sharp, P.A., Sonenberg, N., White, F.M. and Yaffe, M.B., 14-3-3 Sigma Controls Mitotic Translation to Facilitate Cytokinesis.  Nature 446, 329-332 (2007).

355.   Ebert, M.S., Neilson, J.R., and Sharp, P.A. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4, 721-726 (2007).  PMCID 54924

356.   Leung, A.K.L. and Sharp, P.A. MicroRNAs: Safeguard against turmoil. Cell (Review) 130, 581-585 (2007).

357.   Calabrese, J.M., Seila, A.C., Yeo, G.W., and Sharp, P.A. RNA sequence analysis defines Dicer’s role in mouse embryonic stem cells. Proc. Natl. Acad. Sci. 104, 18097-18102 (2007).  PMCID 2084302

358.   Wu, H., Neilson, J.R., Kumar, P., Manocha, M., Shankar, P., Sharp, P.A., and Manjunath, N. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2:e1020 (2007). PMCID PMC2000354

359.   Ventura, A., Young, A.G., Winslow, M.M., Lintault, L., Meissner, A., Erkeland, S.J., Newman, J., Bronson, R.T., Crowley, D., Stone, J.R., Jaenisch, R., Sharp, P.A. and Jacks, T. Targeted deletion reveals essential and overlapping functions of the miR-17~92 family of miRNA clusters. Cell 132, 875-886 (2008). PMCID 2323338.

360.   Kumar, M.S., Erkeland, S.J., Pester, R.E., Chen, C. Y., Ebert, M.S, Sharp, P.A., Jacks, T.  Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA 105, 3903-3908 (2008). PMCID 2268826

361.   Seila, A.C. and Sharp, P.A. Small RNAs tell big stories in Whistler. Meeting Report on Keystone Symposium on RNAi, microRNA and non-coding RNA, March 25-30, 2008. Nature Cell Biology 10, 630-633 (2008).

362.   Sandberg, S., Neilson, J.R., Sarma, A., Sharp, P.A., and Burge, C.B. Proliferating cells express mRNAs with shortened 3’ untranslated regions and fewer microRNA target sites. Science 320, 1643-1647 (2008).  PMCID 2587246

363.   Stern P., Astrof, S., Erkeland, S., Sharp, P.A., and Hynes, R.O. A system for Cre-regulated RNA interference in vivo. Proc. Natl. Acad. Sci. USA 105, 13895-13900 (2008).  PMCID 2532697

364.   Marson, A., Levine, S.S., Cole, M.F., Frampton, G.M., Brambrink, T., Johnstone, S., Guenther, M.G., Johnston, W.K., Wernig, M., Newman, J., Calabrese, M., Dennis, L.M., Volkert, T.L., Gupta, S., Love, J., Hannett, N., Sharp, P.A., Bartel, D.P., Jaenisch, R., and Young, R.A. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521-533 (2008).  PMCID 2586071

365.   Neilson, J.R. and Sharp, P.A. Small RNA regulators of gene expression. Cell 134, 899-902 (Leading Edge BenchMarks) (2008).

366.   Seila, A.C., Calabrese, J.M., Levine, S.S., Yeo, G.W., Rahl, B., Young, R.A., and Sharp P.A.  Divergent transcription from active promoters. Science 322, 1849-1851 (2008).  NIHMSID 94606

367.   Grishok, A., Hoersch, S., and Sharp, P.A. RNA interference and retinoblastoma-related genes are required for repression of endogenous siRNA targets in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 105, 20386-20391 (2008).  PMCID 2629315

368.   Sharp, P.A. The Centrality of RNA (Leading Edge Essay). Cell 136, 577-580 (2009).

369.   Kleppner D.,and Sharp, P.A. Research data in the digital age. Science 325, 368 (2009).

370.   Seila, A.C., Core, L.J., Lis, J.. and Sharp, P.A. Divergent transcription: A new feature of active promoters.  Cell Cycle (review article) 16, 2557-2564 (2009).

371.  Agrawal, A., Min, D.H., Singh, N., Zhu, H., Birjiniuk, A., von Maltzahn, G., Harris, T.J., Xing, D., Woolfenden, S., Sharp, P.A., Charest, A., and Bhatia, S.N. Functional delivery of siRNA in mice using dendriworms.  ACS Nano 3, 2495-2504 (2009).  NIHMSID 138798

372.    Edbauer, D., Neilson, J., Foster, K.A., Wang, C.-F., Seeburg, D.P., Batterton, M.N., Tada, T., Dolan, B.M., Sharp, P.A., and Sheng, M.  Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.  Neuron 65, 373-384    (2010). NIHMSID 181665

373.  Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp, P.A., Young, A.  c-Myc regulates transcriptional pause release.  Cell. 141 432-445. (2010 ) PMCID: PMC2864022

374.  Leung, A.K., and Sharp, P.A.  MicroRNA functions in stress responses.  Mol. Cell 40, 205-215 (2010). PMCID: PMC2996264

375.  Ebert, M.S., and Sharp, P.A.  MicroRNA sponges: progress and possibilities. RNA 16(11), 2043-50 (2010). PMCID: PMC2957044

376.  Ebert, M.S., and Sharp, P.A. Emerging roles for natural microRNA sponges.  Curr. Biol. 12;20(19):R858-61 (2010). PMC Journal in process.

377.   Creyghton, M., Cheng, A., Welstead, G.G., Kooistra, T., Carey, B., Sharp, P.A., Steine, E., Hanna, J., Lodato, M., Frampton, G., Boyer, L., Young, R., and Jaenisch, R. Histone H3K27ac separates active from poised enhancers and predicts developmental state. PNAS. 107, 21931-21936 (2010). PMCID: PMC3003124.

378.  Singh, N., Agrawal, A., Leung, A.K., Sharp, P.A., and Bhatia, S.N. Effect of nanoparticle conjugation on gene silencing by RNA interference.  J. Am. Chem. Soc. 132, 8241-8243 (2010). PMCID: PMC2968757

379.  Goldberg, M.S., Xin, D., Ren, Y., Orsulic, S., Bhatia, S.N., and Sharp, P.A.  Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.  Proc. Natl. Acad. Sci. USA. 108, 745-750 (2011).  PMCID: PMC3021044

380.   Leung, A.K.L., Young, A.G., Bhutkar, A., Zheng, G.X., Bosson, A.D., Nielsen, C.B., and Sharp, P.A. Genomewide identification of Ago2 binding sites from mouse embryonic stem cells with and without mature microRNAs.  Nat. Struct. Mol. Biol. 18, 237-44 (2010).  PMCID: PMC3078052

381.    Leung, A.K.L., Vyas, S., Rood, J.E., Bhutkar, A., Chang, P., and Sharp, P.A.  Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 42, 489-99 (2011). PMCID, Journal in process.

382.   Flynn, R.A., Almada, A.E., Zamudio, J.R., and Sharp, P.A..  Antisense RNA polymerase II divergent transcripts are P-TEFb-dependent substrates for the RNA exosome. Proc. Natl. Acad. Sci USA 108, 10460-10465 (2011).  PMCID: PMC3127934.

383.   Zheng, G., Ravi, A., Calabrese, J.M., Medeiros, L.A., Kirak, O., Dennis, L.M., Jaenisch, R., Burge, C.B., and Sharp, P.A. A latent pro-survival function for the Mir-290-295 cluster in mouse embryonic stem cells. PLoS Genetics 7, e1002054 (2011).  PMCID: PMC3088722

384.   Meenhuis, A., van Veelen, P.A., van den Berge, I.J., Sun, S.M., Taskesen, E., Stern, P., de Ru, A.H., van Adrichem, A.J., Demmers, J., Jongen-Lavrencic, M., Löwenberg, B., Touw, I.P., Sharp, P.A., and Erkeland, S.J. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood 118, 916-25 (2011). PMCID: PMC3148171

385    Zheng, G., Ravi, A., Gould, G.M., Burge, C.B., and Sharp, PA.  Genome-wide impact of a recently expanded microRNA cluster in mouse.  Proc. Natl. Acad. Sci. USA 108, 15804-15809 (2011). PMCID:  PMC3179086

386.   Mukherji, S., Ebert, M.S., Zheng, G.Z., Tsang, J.S., Sharp, P.A., and van Oudenaarden, A. MicroRNAs can generate thresholds in target gene expression.  Nature Genetics 43, 854-860 (2011).  PMCID:  PMC3163764

387. Wilusz, J.E., Whipple, J.M., Phizicky, E.M., and Sharp, P.A. tRNAs marked with CCACCA are targeted for degradation. Science. 334, 817-21 (2011). PMCID: PMC3273417

388. Medeiros, L.A., Dennis, L.M., Gil,l M.E., Houbaviy, H., Markoulaki, S., Fu, D., White, A.C., Kirak, O., Sharp, P.A., Page, D.C., and Jaenisch, R. Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects. Proc. Natl. Acad. Sci. USA. 108, 14163-14168 (2011). PMCID: PMC3161528

389. Goldberg, M., Sharp, P.A. cPyruvate kinase M2-specifi c siRNA induces apoptosis and tumor regression. J Exp Med. 209, 217-24 (2012). PMCID: PMC Journal In Process

390.  Gurtan, A.M., Lu, V., Bhutkar, A., and Sharp, P.A.  In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA 18, 1116-22 (2012) PMCID: PMC3358635. 

391.  Ravi, A., Gurtan, A.M., Kumar, M.S., Bhutkar, A., Chin, C., Lu, V., Lees, J.A., Jacks, T., and Sharp, P.A. Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. Cancer Cell 21, 848-55 (2012) PMCID: PMC3385871

392.  Ebert, M.S., and Sharp, P.A.  Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-24 (2012) PMCID: PMC3351105

393.  Wilusz, J.E., JnBaptiste, C.K., Lu, L.Y., Kuhn, C.-D., Joshua-Tor, L., and Sharp, P.A.  A triple helix stabilizes the 3’ ends of long noncoding RNAs that lack poly(A) tails. Genes Dev 26, 2392-407 (2012). PMCID: PMC3489998

394.  Sigova, A.A., Mullen, A.C., Moline, B., Gupta, S., Orlando, D.A., Guenther, M.G., Almada, A.E., Lin, C., Sharp, P.A., Giallourakis, C., and Young, R.A. Divergent transcription of lncRNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A 110, 2876-81 (2013). PMCID Journal in process

395.  Leung, A.K., and Sharp, P.A. Quantifying argonaute proteins in and out of GW/P-bodies: Implications in microRNA activities. Adv Exp Med Biol. 768, 165-182 (2013). (Review)

 

 

 



MIT Koch Institute for Integrative Cancer Research at MIT